Editorial Policy

Content Creation Process

All content on DecodeMyBio is based on peer-reviewed literature and published clinical guidelines. Articles, gene pages, and medication pages are written in plain language for educational purposes. We aim to make pharmacogenomic concepts accessible without oversimplifying the underlying science or making claims that extend beyond the supporting evidence.

Author Qualifications & Review Process

Content is researched and drafted by the DecodeMyBio Editorial Team, which reviews pharmacogenomics literature, CPIC guideline updates, and FDA regulatory changes on an ongoing basis. Each article goes through a multi-step process:

• Research — primary sources (CPIC guidelines, PubMed-indexed studies, FDA tables) are identified and reviewed.
• Drafting — content is written in plain language, with clinical claims traced to specific guideline citations.
• Accuracy review — every factual claim is cross-referenced against the cited source before publication.
• Periodic re-review — published content is revisited when CPIC or DPWG release updated guidelines, or when new evidence materially changes a recommendation.

To understand how we apply these standards in our analysis pipeline, see our methodology and data sources.

Evidence Standards

DecodeMyBio relies primarily on the following sources:

• CPIC — Clinical Pharmacogenetics Implementation Consortium guidelines for drug-gene interactions.
• PharmGKB — Pharmacogenomics knowledge base for guideline annotations and clinical evidence summaries.
• FDA — Table of Pharmacogenomic Biomarkers in Drug Labeling, used for contextual regulatory information.
• PharmVar — Pharmacogene Variation Consortium for allele definitions and nomenclature.

We do not use non-evidence-based supplement protocols, proprietary algorithms without published methodology, or unpublished data sources. To see how this compares with other testing services, read our pharmacogenomic testing comparison. For details on how we apply these sources in our analysis, see our Methodology page.

Conflict of Interest Disclosure

DecodeMyBio offers paid pharmacogenomic reports generated from consumer DNA data. All educational content — including articles, gene pages, and medication pages — is written to inform, not to promote the purchase of reports. Content is designed to be useful regardless of whether a reader uses DecodeMyBio's services.

DecodeMyBio does not accept advertising, sponsored content, or affiliate payments from pharmaceutical companies, testing laboratories, or supplement manufacturers.

Medical Disclaimer Policy

DecodeMyBio is not a medical device, diagnostic tool, or healthcare provider. All content — including educational articles, gene and medication pages, and reports — is informational only. No content on this site constitutes medical advice or a recommendation to start, stop, or change any medication.

Users should always consult a qualified healthcare provider before making medication decisions. For a detailed discussion of the analytical boundaries of consumer pharmacogenomic analysis, see our limitations page.

Corrections Policy

If you identify an error in any content on DecodeMyBio — whether factual, typographic, or interpretive — please contact us at support@decodemybio.com. We are committed to reviewing all reported inaccuracies and issuing corrections promptly.